Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DeepBiome Therapeutics

DeepBiome Therapeutics
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Owner and operator of next generation drug discovery platform. The company's drug discovery platform leverages deep learning, microbiome and synthetic biology technologies, enabling drug companies to shift the drug discovery paradigm.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Social/Platform Software
Primary Office
  • 127 Western Avenue
  • Allston, MA 02134
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DeepBiome Therapeutics’s full profile, request a free trial.

DeepBiome Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 15-Oct-2017 000 Completed Generating Revenue
1. Seed Round 01-Sep-2017 000 000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

DeepBiome Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Pagliuca Harvard Life Lab Accelerator/Incubator Minority 000 0000 000000 0

DeepBiome Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Chengwei Luo Founder & Chief Executive Officer